• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体疫苗的设计考虑因素:配方参数对与脂质体相关抗原结合的抗体和细胞介导免疫应答的影响。

Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

机构信息

Biosciences Division, SRI International, 140 Research Drive, Harrisonburg, VA 22802, United States.

出版信息

Vaccine. 2012 Mar 16;30(13):2256-72. doi: 10.1016/j.vaccine.2012.01.070. Epub 2012 Feb 2.

DOI:10.1016/j.vaccine.2012.01.070
PMID:22306376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3296885/
Abstract

Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for induction of antibody and T lymphocyte responses to associated subunit antigens. In the last 15 years, liposome vaccine technology has matured and now several vaccines containing liposome-based adjuvants have been approved for human use or have reached late stages of clinical evaluation. Given the intensifying interest in liposome-based vaccines, it is important to understand precisely how liposomes interact with the immune system and stimulate immunity. It has become clear that the physicochemical properties of liposomal vaccines - method of antigen attachment, lipid composition, bilayer fluidity, particle charge, and other properties - exert dramatic effects on the resulting immune response. Here, we present a comprehensive review of the physicochemical properties of liposomal vaccines and how they influence immune responses. A discussion of novel and emerging immunomodulators that are suitable for inclusion in liposomal vaccines is also presented. Through a comprehensive analysis of the body of liposomal vaccine literature, we enumerate a series of principles that can guide the rational design of liposomal vaccines to elicit immune responses of a desired magnitude and quality. We also identify major unanswered questions in the field, pointing the direction for future study.

摘要

脂质体(磷脂双层囊泡)是诱导抗体和 T 淋巴细胞对相关亚单位抗原反应的多功能且稳健的递药系统。在过去的 15 年中,脂质体疫苗技术已经成熟,现在已经有几种包含基于脂质体的佐剂的疫苗被批准用于人体使用或已进入临床评估的后期阶段。鉴于人们对基于脂质体的疫苗的兴趣日益浓厚,了解脂质体与免疫系统的相互作用以及刺激免疫的机制非常重要。很明显,脂质体疫苗的物理化学特性——抗原附着的方法、脂质组成、双层流动性、颗粒电荷和其他特性——对产生的免疫反应有显著影响。在这里,我们全面回顾了脂质体疫苗的物理化学特性以及它们如何影响免疫反应。还讨论了适合包含在脂质体疫苗中的新型和新兴免疫调节剂。通过对脂质体疫苗文献的全面分析,我们列举了一系列原则,可以指导脂质体疫苗的合理设计,以产生所需大小和质量的免疫反应。我们还确定了该领域的主要未解决问题,为未来的研究指明了方向。

相似文献

1
Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.脂质体疫苗的设计考虑因素:配方参数对与脂质体相关抗原结合的抗体和细胞介导免疫应答的影响。
Vaccine. 2012 Mar 16;30(13):2256-72. doi: 10.1016/j.vaccine.2012.01.070. Epub 2012 Feb 2.
2
Liposomal vaccine delivery systems.脂质体疫苗递送系统。
Expert Opin Drug Deliv. 2011 Apr;8(4):505-19. doi: 10.1517/17425247.2011.558081. Epub 2011 Mar 18.
3
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.脂质体疫苗制剂作为预防性制剂:现代疫苗的设计考虑因素。
J Nanobiotechnology. 2017 Nov 17;15(1):83. doi: 10.1186/s12951-017-0319-9.
4
Designing liposomal adjuvants for the next generation of vaccines.设计用于下一代疫苗的脂质体佐剂。
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):85-96. doi: 10.1016/j.addr.2015.11.005. Epub 2015 Nov 11.
5
Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.脂质体亚单位疫苗:脂多糖A和氢氧化铝对免疫原性的影响。
J Pharm Sci. 1996 Dec;85(12):1286-9. doi: 10.1021/js9601593.
6
Liposomal presentation of antigens for human vaccines.用于人类疫苗的抗原脂质体呈递。
Pharm Biotechnol. 1995;6:325-45. doi: 10.1007/978-1-4615-1823-5_13.
7
Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.阐明蛋白质抗原吸附到CAF/NAF脂质体疫苗佐剂系统的机制:电荷、流动性和抗原与脂质比例的影响。
Biochim Biophys Acta. 2014 Aug;1838(8):2001-10. doi: 10.1016/j.bbamem.2014.04.013. Epub 2014 Apr 25.
8
Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach.采用实验设计方法预测脂质体脂质组成对脂质体大小、zeta电位及脂质体诱导的树突状细胞成熟的影响。
Eur J Pharm Biopharm. 2015 Aug;94:427-35. doi: 10.1016/j.ejpb.2015.06.026. Epub 2015 Jul 2.
9
Liposomes as vaccine delivery systems: a review of the recent advances.脂质体作为疫苗递送系统:近期进展综述
Ther Adv Vaccines. 2014 Nov;2(6):159-82. doi: 10.1177/2051013614541440.
10
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.疫苗佐剂系统:增强亚单位蛋白抗原的功效
Int J Pharm. 2008 Dec 8;364(2):272-80. doi: 10.1016/j.ijpharm.2008.04.036. Epub 2008 Apr 30.

引用本文的文献

1
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.核酸疫苗:创新、疗效及在高危人群中的应用
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
2
Superior Potency of Synthetic Virus-like Structures in Vaccine-Induced Antibody Responses Compared to Qβ Bacteriophage Virus-like Particles.与Qβ噬菌体病毒样颗粒相比,合成病毒样结构在疫苗诱导的抗体反应中具有更高的效力。
Viruses. 2025 Apr 17;17(4):579. doi: 10.3390/v17040579.
3
Potential of the Nano-Encapsulation of Antioxidant Molecules in Wound Healing Applications: An Innovative Strategy to Enhance the Bio-Profile.

本文引用的文献

1
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.聚乙二醇化 DDA:TDB 脂质体佐剂可降低疫苗储库效应并改变 Th1/Th2 免疫应答。
J Control Release. 2012 Feb 28;158(1):72-7. doi: 10.1016/j.jconrel.2011.10.012. Epub 2011 Oct 18.
2
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.RTS,S/AS01 疟疾疫苗在非洲儿童中进行的 3 期临床试验的初步结果。
N Engl J Med. 2011 Nov 17;365(20):1863-75. doi: 10.1056/NEJMoa1102287. Epub 2011 Oct 18.
3
CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets.
抗氧化分子纳米封装在伤口愈合应用中的潜力:一种增强生物特性的创新策略。
Molecules. 2025 Jan 31;30(3):641. doi: 10.3390/molecules30030641.
4
Double Peptide-Functionalized Carboxymethyl Chitosan-Coated Liposomes Loaded with Dexamethasone as a Potential Strategy for Active Targeting Drug Delivery.负载地塞米松的双肽功能化羧甲基壳聚糖包被脂质体作为主动靶向给药的潜在策略
Int J Mol Sci. 2025 Jan 22;26(3):922. doi: 10.3390/ijms26030922.
5
A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters.一种包裹在含有1,2-二油酰-sn-甘油-3-磷酸乙醇胺的磷脂脂质纳米颗粒中的基于刺突蛋白的mRNA疫苗,在仓鼠中诱导了强效的B细胞和T细胞反应,并与预防SARS-CoV-2感染及类似COVID-19症状相关。
Vaccines (Basel). 2025 Jan 8;13(1):47. doi: 10.3390/vaccines13010047.
6
Therapeutic ultrasound: an innovative approach for targeting neurological disorders affecting the basal ganglia.治疗性超声:一种针对影响基底神经节的神经系统疾病的创新方法。
Front Neuroanat. 2024 Oct 2;18:1469250. doi: 10.3389/fnana.2024.1469250. eCollection 2024.
7
An Integrated Signaling Threshold Initiates IgG Response toward Virus-like Immunogens.一种整合的信号阈值启动针对病毒样免疫原的 IgG 应答。
J Immunol. 2024 Oct 15;213(8):1061-1075. doi: 10.4049/jimmunol.2400101.
8
Building a Simplistic Automatic Extruder: Instrument Development Opportunities for the Laboratory.构建简易自动挤出机:实验室的仪器开发机遇
J Chem Educ. 2024 Aug 1;101(8):3292-3300. doi: 10.1021/acs.jchemed.4c00287. eCollection 2024 Aug 13.
9
Minimal Determinants for Lifelong Antiviral Antibody Responses in Mice from a Single Exposure to Virus-like Immunogens at Low Doses.单次低剂量接触病毒样免疫原后小鼠终身抗病毒抗体反应的最小决定因素
Vaccines (Basel). 2024 Apr 11;12(4):405. doi: 10.3390/vaccines12040405.
10
Nanoparticle-neutrophils interactions for autoimmune regulation.纳米颗粒-中性粒细胞相互作用的自身免疫调控。
Adv Drug Deliv Rev. 2024 Jun;209:115316. doi: 10.1016/j.addr.2024.115316. Epub 2024 Apr 23.
CAF01 增强了雪貂对流感疫苗的免疫反应和效力。
PLoS One. 2011;6(8):e22891. doi: 10.1371/journal.pone.0022891. Epub 2011 Aug 5.
4
The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production.DDA:TDB 脂质体佐剂的囊泡大小在细胞介导的免疫反应中起作用,但对抗体产生没有显著影响。
J Control Release. 2011 Sep 5;154(2):131-7. doi: 10.1016/j.jconrel.2011.05.019. Epub 2011 May 27.
5
The RTS,S vaccine candidate for malaria.疟疾的 RTS,S 疫苗候选物。
Expert Rev Vaccines. 2011 May;10(5):589-99. doi: 10.1586/erv.11.57.
6
Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.最近使用含有 MPL 和 QS-21 的佐剂系统的疫苗的临床经验。
Expert Rev Vaccines. 2011 Apr;10(4):471-86. doi: 10.1586/erv.11.29.
7
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.脂肪酸诱导的 NLRP3-ASC 炎性体激活干扰胰岛素信号转导。
Nat Immunol. 2011 May;12(5):408-15. doi: 10.1038/ni.2022. Epub 2011 Apr 10.
8
Liposomal vaccine delivery systems.脂质体疫苗递送系统。
Expert Opin Drug Deliv. 2011 Apr;8(4):505-19. doi: 10.1517/17425247.2011.558081. Epub 2011 Mar 18.
9
Programming the magnitude and persistence of antibody responses with innate immunity.用先天免疫来编程抗体反应的强度和持久性。
Nature. 2011 Feb 24;470(7335):543-7. doi: 10.1038/nature09737.
10
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.层间交联的多层囊泡作为合成疫苗,引发强烈的体液和细胞免疫应答。
Nat Mater. 2011 Mar;10(3):243-51. doi: 10.1038/nmat2960. Epub 2011 Feb 20.